BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 25481844)

  • 1. Isolation and drug susceptibility of Candida parapsilosis sensu lato and other species of C. parapsilosis complex from patients with blood stream infections and proposal of a novel LAMP identification method for the species.
    Trabasso P; Matsuzawa T; Fagnani R; Muraosa Y; Tominaga K; Resende MR; Kamei K; Mikami Y; Schreiber AZ; Moretti ML
    Mycopathologia; 2015 Feb; 179(1-2):53-62. PubMed ID: 25481844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Candida parapsilosis (sensu lato) isolated from hospitals located in the Southeast of Brazil: Species distribution, antifungal susceptibility and virulence attributes.
    Ziccardi M; Souza LO; Gandra RM; Galdino AC; Baptista AR; Nunes AP; Ribeiro MA; Branquinha MH; Santos AL
    Int J Med Microbiol; 2015 Dec; 305(8):848-59. PubMed ID: 26319940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular epidemiology and antifungal susceptibility of Candida parapsilosis sensu stricto, Candida orthopsilosis, and Candida metapsilosis in Taiwan.
    Chen YC; Lin YH; Chen KW; Lii J; Teng HJ; Li SY
    Diagn Microbiol Infect Dis; 2010 Nov; 68(3):284-92. PubMed ID: 20851551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Candida orthopsilosis fungemias in a Spanish tertiary care hospital: incidence, epidemiology and antifungal susceptibility.
    Blanco-Blanco MT; Gómez-García AC; Hurtado C; Galán-Ladero MA; Lozano Mdel C; García-Tapias A; Blanco MT
    Rev Iberoam Micol; 2014; 31(2):145-8. PubMed ID: 23680638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective multicenter study of the epidemiology, molecular identification, and antifungal susceptibility of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis isolated from patients with candidemia.
    Cantón E; Pemán J; Quindós G; Eraso E; Miranda-Zapico I; Álvarez M; Merino P; Campos-Herrero I; Marco F; de la Pedrosa EG; Yagüe G; Guna R; Rubio C; Miranda C; Pazos C; Velasco D;
    Antimicrob Agents Chemother; 2011 Dec; 55(12):5590-6. PubMed ID: 21930869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevalence of Candida parapsilosis, C. orthopsilosis and C. metapsilosis in candidemia over a 5-year period at Nantes hospital and in vitro susceptibility to three echinocandins by E-test®].
    Thierry G; Morio F; Le Pape P; Gay-Andrieu F; Barre O; Miegeville M
    Pathol Biol (Paris); 2011 Feb; 59(1):52-6. PubMed ID: 20832195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and antifungal susceptibility patterns of new cryptic species inside the species complexes Candida parapsilosis and Candida glabrata among blood isolates from a Spanish tertiary hospital.
    Miranda-Zapico I; Eraso E; Hernández-Almaraz JL; López-Soria LM; Carrillo-Muñoz AJ; Hernández-Molina JM; Quindós G
    J Antimicrob Chemother; 2011 Oct; 66(10):2315-22. PubMed ID: 21795259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simple, Low-Cost Detection of Candida parapsilosis Complex Isolates and Molecular Fingerprinting of Candida orthopsilosis Strains in Kuwait by ITS Region Sequencing and Amplified Fragment Length Polymorphism Analysis.
    Asadzadeh M; Ahmad S; Hagen F; Meis JF; Al-Sweih N; Khan Z
    PLoS One; 2015; 10(11):e0142880. PubMed ID: 26580965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of fluconazole resistance in a series of Candida parapsilosis isolates from a persistent candidemia patient with prolonged antifungal therapy.
    Zhang L; Xiao M; Watts MR; Wang H; Fan X; Kong F; Xu YC
    BMC Infect Dis; 2015 Aug; 15():340. PubMed ID: 26282840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics and treatment outcomes of patients with candidaemia due to Candida parapsilosis sensu lato species at a medical centre in Taiwan, 2000-12.
    Chen CY; Sheng WH; Huang SY; Chou WC; Yao M; Tang JL; Tsay W; Tien HF; Hsueh PR
    J Antimicrob Chemother; 2015 May; 70(5):1531-8. PubMed ID: 25558079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution, virulence attributes and antifungal susceptibility patterns of Candida parapsilosis complex strains isolated from clinical samples.
    Tosun I; Akyuz Z; Guler NC; Gulmez D; Bayramoglu G; Kaklikkaya N; Arikan-Akdagli S; Aydin F
    Med Mycol; 2013 Jul; 51(5):483-92. PubMed ID: 23216051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Candida parapsilosis sensu stricto and the closely related species Candida orthopsilosis and Candida metapsilosis in vulvovaginal candidiasis.
    Zhu Y; Shan Y; Fan S; Li J; Liu X
    Mycopathologia; 2015 Feb; 179(1-2):111-8. PubMed ID: 25322705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of Candida parapsilosis complex isolates.
    de Toro M; Torres MJ; Maite R; Aznar J
    Clin Microbiol Infect; 2011 Mar; 17(3):418-24. PubMed ID: 20636431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular differentiation and antifungal susceptibilities of Candida parapsilosis isolated from patients with bloodstream infections.
    Tay ST; Na SL; Chong J
    J Med Microbiol; 2009 Feb; 58(Pt 2):185-191. PubMed ID: 19141735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization and antifungal susceptibility of the Candida parapsilosis species complex of clinical isolates from Monterrey, Mexico.
    Treviño-Rangel Rde J; Garza-González E; González JG; Bocanegra-García V; Llaca JM; González GM
    Med Mycol; 2012 Oct; 50(7):781-4. PubMed ID: 22493945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence, distribution and antifungal susceptibility profiles of Candida parapsilosis, Candida orthopsilosis and Candida metapsilosis bloodstream isolates.
    Bonfietti LX; Martins MDA; Szeszs MW; Pukiskas SBS; Purisco SU; Pimentel FC; Pereira GH; Silva DC; Oliveira L; Melhem MSC
    J Med Microbiol; 2012 Jul; 61(Pt 7):1003-1008. PubMed ID: 22493277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency, virulence factors and antifungal susceptibility of Candida parapsilosis species complex isolated from patients with candidemia in the central region of Argentina.
    Vigezzi C; Icely PA; Dudiuk C; Rodríguez E; Miró MS; Castillo GDV; Azcurra AI; Abiega C; Caeiro JP; Riera FO; García-Effrón G; Sotomayor CE
    J Mycol Med; 2019 Dec; 29(4):285-291. PubMed ID: 31668524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial susceptibility and clinical outcomes of Candida parapsilosis bloodstream infections in a tertiary teaching hospital in Northern Taiwan.
    Lin CC; Liu CP; Hsieh FC; Lee CM; Wang WS
    J Microbiol Immunol Infect; 2015 Oct; 48(5):552-8. PubMed ID: 25315213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance.
    Xiao M; Fan X; Chen SC; Wang H; Sun ZY; Liao K; Chen SL; Yan Y; Kang M; Hu ZD; Chu YZ; Hu TS; Ni YX; Zou GL; Kong F; Xu YC
    J Antimicrob Chemother; 2015 Mar; 70(3):802-10. PubMed ID: 25473027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.